论文部分内容阅读
随着社会发展,缺血性脑血管病发病率逐年升高,而患者年复发率可达14%[1],成为日益严重的问题,造成患者残疾,生活质量下降。目前,抗血小板聚集及调脂是治疗脑血管疾病的重要措施之一,氯吡格雷的抗血小板作用在缺血性脑血管疾病中已得到了肯定,但与阿司匹林联用是否合适有待进一步的临床研究。为此笔者对我院近3年新发缺血性脑血管病伴有颅内血管狭窄患者66例,联合用药疗效予以分析,报
With the development of society, the incidence of ischemic cerebrovascular disease is increasing year by year, and the annual recurrence rate of patients reaches up to 14% [1], which has become an increasingly serious problem that causes disability and quality of life of patients. Currently, anti-platelet aggregation and lipid-lowering is one of the important measures for the treatment of cerebrovascular disease. The anti-platelet effect of clopidogrel has been affirmed in ischemic cerebrovascular disease. However, whether aspirin is suitable for further clinical treatment the study. To this end, the author of our hospital nearly 3 years of new ischemic cerebrovascular disease associated with intracranial vascular stenosis in 66 patients, the combined effect of the drug be analyzed, reported